日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characteristics and outcomes of patients with endometriosis and malignant or borderline ovarian tumors: real-world evidence from an ESGO centre of excellence

子宫内膜异位症合并恶性或交界性卵巢肿瘤患者的特征和预后:来自ESGO卓越中心的真实世界证据

Beck, Maximilian Heinz; Kordowitzki, Paul; Roser, Eva; Trelinska-Finger, Anna; Schoof, Emily; Chinczewski, Lukas; Mechsner, Sylvia; Sehouli, Jalid

Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancer

联合声明:德国卵巢癌委员会、德国东北部妇科肿瘤学会 (NOGGO)、奥地利妇科肿瘤学会 (AGO Austria) 和瑞士妇科肿瘤学会 (AGO Swiss) 关于在晚期卵巢癌中使用同源重组修复缺陷 (HRD) 检测的联合声明

Chinczewski, Lukas; Harter, Philipp; Heukamp, Lukas; Mayr, Doris; Grimm, Christoph; Heinzelmann-Schwarz, Viola; Wimberger, Pauline; Mahner, Sven; Braicu, Ioana Elena; Schmitt, Wolfgang; Denkert, Carsten; Sehouli, Jalid

The Charité protocol for surveillance, treatment and after-care management in women with Lynch syndrome

夏里特医院针对林奇综合征女性患者的监测、治疗和后续护理管理方案

Chinczewski, Lukas; Chekerov, Radoslav; Daum, Severin; Ott, Claus-Eric; Sehouli, Jalid